Skip to content

Continuous vs. intermittent intraoperative neuromonitoring for reduction of transient recurrent laryngeal nerve palsy in thyroid surgery - a prospective randomized controlled multicenter clinical trial (CITY-Trial)

Continuous vs. intermittent intraoperative neuromonitoring for reduction of transient recurrent laryngeal nerve palsy in thyroid surgery - a prospective randomized controlled multicenter clinical trial (CITY-Trial) - CITY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033520
Enrollment
2426
Registered
2024-03-22
Start date
2024-02-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign goiter E04

Interventions

Group 1: continuous intraoperative neuromonitoring C-IONM Group 2: intermittent intraoperative neuromonitoring I-IONM

Sponsors

Philipps-Universität Marburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients undergoing total thyroidectomy, or hemithyroidectomy for potentially benign goiter, life expectancy = 12 months, informed consent

Exclusion criteria

Exclusion criteria: proven malignancy, preoperative recurrent laryngeal nerve palsy, previous thyroid surgery, previous parathyroid surgery, previous neck dissection, neurophysiological deficiencies, severe psychiatric or neurologic disease, participation in another intervention trial with interference of intervention and outcome, inability to follow instructions given by the investigator (e.g. insufficient command of language)

Design outcomes

Primary

MeasureTime frame
rate of transient postoperative recurrent laryngeal nerve palsy: proportion of nerves with RLN palsy as assessed on the first (or second) postoperative day, based on the number of nerves at risk (NAR) as denominator. Depending on whether a uni- or bilateral surgery is performed, one or two nerves per patient are at risk. RLN palsy is determined by laryngoscopy by a blinded head and neck (HN) specialist.

Secondary

MeasureTime frame
proportion with transient resp. permanent RLN palsy both per NAR and per patient (if the nerve function recovers within 6 months after surgery RLN palsy is defined as transient, otherwise it is defined as permanent); proportion of two-stage resections, operating time, IONM failures, histopathological result

Countries

Germany

Contacts

Public ContactElisabeth Maurer

Philipps-Universität Marburg

maurere@med.uni-marburg.de+4964215866441

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026